Navigation Links
Where are new schizophrenia drugs? Experts convene to explore genetic and epigenetic solutions
Date:3/4/2011

NEW YORK, March 4, 2011 Despite significant investment in research and development by pharmaceutical companies, the last decade has seen a marked decline in the number of drugs developed and approved for schizophrenia. A multi-day symposium at the New York Academy of Sciences on Wednesday, March 9 Friday, March 11 will convene world-leading experts in clinical, translational, and basic neuroscience to address this problem by examining novel, state-of-the-art approaches to schizophrenia drug development.

More than 20 speakers will describe a variety of promising approaches to developing therapies, including using genetic studies to identify new targets, improving animal models, targeting the epigenome, identifying new small molecule targets, and understanding the functioning of neural circuits. To register or for more information, see www.nyas.org/Schizophrenia2011.

WHAT:

A Scientific Symposium: Advancing Drug Discovery for Schizophrenia

WHO:

Organizers

Stephen Marder, MD, University of California, Los Angeles School of Medicine

Bita Moghaddam, PhD, University of Pittsburgh

Bryan Roth, MD, PhD, University of North Carolina School of Medicine

Keynote Speakers:

Eric J.Nestler, MD, PhD, Mount Sinai Medical Center

Edward Scolnick, MD, The Broad Institute of Massachusetts Institute of Technology and Harvard University

Patrick F.Sullivan, MD, The University of North Carolina at Chapel Hill

WHEN:

Wednesday, March 9, 2011 | 5:30 pm poster session/reception
Thursday, March 10, 2011 | 8:00 am 6:00 pm
Friday, March 11, 2011 | 8:15 am 6:00 pm

WHERE:

The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY


'/>"/>

Contact: Adrienne Burke
aburke@nyas.org
212-298-8655
New York Academy of Sciences
Source:Eurekalert

Page: 1

Related medicine news :

1. Where MRSA colonizes on the human body
2. Many hospital emergency department visits could be treated elsewhere, study finds
3. Where the fats at
4. Oxford House: Where Stories of Recovery Are Born
5. Mona Pearl On Growth Models - Past, Present and Future: Where do Middle Market Companies Go For Global Expansion Expertise?
6. Where Do Pets Go When They Dream?
7. Mobile and Patented: DATA-TO-CAMERA TOGGLE on handheld device replaces old camera and clipboard approach everywhere! Beats IPAD to camera punch too.....
8. UltraLinq Healthcare Solutions and Advanced Imaging Consultants Partner to Provide an Anytime, Anywhere Image Management Solution to the Mobile Market
9. Stanford/Packard study finds surprising disparity in where chronically ill kids hospitalized
10. DSPanel's New Mobile Analytics Server for Business Intelligence: Data Analysis, Monitoring and Planning When and Where You Need It
11. Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... SAN DIEGO , Oct. 12, 2017 ... has recognized the company with their  2017 New Product Innovation ... is based on extensive primary and secondary medical device market ... AVACEN Medical, through its first-to-market OTC, drug-free pain relief product, ... a unique approach to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology: